{"id":3240,"date":"2024-03-19T11:22:23","date_gmt":"2024-03-19T10:22:23","guid":{"rendered":"https:\/\/invivo.partners\/?p=3240"},"modified":"2024-04-17T11:22:37","modified_gmt":"2024-04-17T09:22:37","slug":"telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo","status":"publish","type":"post","link":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/","title":{"rendered":"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO."},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-3245 size-medium alignleft\" src=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Subhendu-Basu-257x300.jpg\" alt=\"\" width=\"257\" height=\"300\" srcset=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Subhendu-Basu-257x300.jpg 257w, https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Subhendu-Basu-160x187.jpg 160w, https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Subhendu-Basu.jpg 600w\" sizes=\"auto, (max-width: 257px) 100vw, 257px\" \/><\/p>\n<ul>\n<li><strong>El Dr. Basu aporta m\u00e9s de 20 anys d&#8217;experi\u00e8ncia t\u00e8cnica i de gesti\u00f3 profunda en els \u00e0mbits acad\u00e8mic i biotecnol\u00f2gic.<\/strong><\/li>\n<li><strong>El Dr. Basu s&#8217;uneix a l&#8217;empresa per liderar-la en la seva pr\u00f2xima fase de desenvolupament, on es centrar\u00e0 en definir l&#8217;estrat\u00e8gia, ampliar el pipeline i impulsar el desenvolupament corporatiu.<\/strong><\/li>\n<\/ul>\n<p>M\u00e9s <a href=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/202403-PR-Telum.pdf\" target=\"_blank\" rel=\"noopener\">info<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Dr. Basu aporta m\u00e9s de 20 anys d&#8217;experi\u00e8ncia t\u00e8cnica i de gesti\u00f3 profunda en els \u00e0mbits acad\u00e8mic i biotecnol\u00f2gic. El Dr. Basu s&#8217;uneix a l&#8217;empresa per liderar-la en la seva pr\u00f2xima fase de desenvolupament, on es centrar\u00e0 en definir l&#8217;estrat\u00e8gia, ampliar el pipeline i impulsar el desenvolupament corporatiu. M\u00e9s info<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[516],"tags":[],"class_list":["post-3240","post","type-post","status-publish","format-standard","hentry","category-noticias-ca"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO. - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO. - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"El Dr. Basu aporta m\u00e9s de 20 anys d&#8217;experi\u00e8ncia t\u00e8cnica i de gesti\u00f3 profunda en els \u00e0mbits acad\u00e8mic i biotecnol\u00f2gic. El Dr. Basu s&#8217;uneix a l&#8217;empresa per liderar-la en la seva pr\u00f2xima fase de desenvolupament, on es centrar\u00e0 en definir l&#8217;estrat\u00e8gia, ampliar el pipeline i impulsar el desenvolupament corporatiu. M\u00e9s info\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T10:22:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-17T09:22:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Subhendu-Basu-257x300.jpg\" \/>\n<meta name=\"author\" content=\"Bego\u00f1a Aguirre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bego\u00f1a Aguirre\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\"},\"author\":{\"name\":\"Bego\u00f1a Aguirre\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee\"},\"headline\":\"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO.\",\"datePublished\":\"2024-03-19T10:22:23+00:00\",\"dateModified\":\"2024-04-17T09:22:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\"},\"wordCount\":72,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\",\"url\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\",\"name\":\"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO. - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2024-03-19T10:22:23+00:00\",\"dateModified\":\"2024-04-17T09:22:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee\",\"name\":\"Bego\u00f1a Aguirre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g\",\"caption\":\"Bego\u00f1a Aguirre\"},\"url\":\"https:\/\/invivo.partners\/ca\/author\/bego\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO. - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/","og_locale":"ca_ES","og_type":"article","og_title":"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO. - Invivo Partners","og_description":"El Dr. Basu aporta m\u00e9s de 20 anys d&#8217;experi\u00e8ncia t\u00e8cnica i de gesti\u00f3 profunda en els \u00e0mbits acad\u00e8mic i biotecnol\u00f2gic. El Dr. Basu s&#8217;uneix a l&#8217;empresa per liderar-la en la seva pr\u00f2xima fase de desenvolupament, on es centrar\u00e0 en definir l&#8217;estrat\u00e8gia, ampliar el pipeline i impulsar el desenvolupament corporatiu. M\u00e9s info","og_url":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/","og_site_name":"Invivo Partners","article_published_time":"2024-03-19T10:22:23+00:00","article_modified_time":"2024-04-17T09:22:37+00:00","og_image":[{"url":"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Subhendu-Basu-257x300.jpg"}],"author":"Bego\u00f1a Aguirre","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Bego\u00f1a Aguirre","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/"},"author":{"name":"Bego\u00f1a Aguirre","@id":"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee"},"headline":"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO.","datePublished":"2024-03-19T10:22:23+00:00","dateModified":"2024-04-17T09:22:37+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/"},"wordCount":72,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Noticias"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/","url":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/","name":"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO. - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2024-03-19T10:22:23+00:00","dateModified":"2024-04-17T09:22:37+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/2024\/03\/19\/telum-therapeutics-nomena-el-dr-subhendu-basu-com-a-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Telum Therapeutics nomena el Dr. Subhendu Basu com a CEO."}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee","name":"Bego\u00f1a Aguirre","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g","caption":"Bego\u00f1a Aguirre"},"url":"https:\/\/invivo.partners\/ca\/author\/bego\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/3240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/comments?post=3240"}],"version-history":[{"count":1,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/3240\/revisions"}],"predecessor-version":[{"id":3253,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/3240\/revisions\/3253"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=3240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/categories?post=3240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tags?post=3240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}